Reckless J, Grainger D J
Department of Medicine, University of Cambridge, Addenbrookes Hospital, Box 157, Hills Road, Cambridge CB2 2QQ, UK.
Biochem J. 1999 Jun 15;340 ( Pt 3)(Pt 3):803-11.
We have identified an amino acid sequence, termed peptide 3, corresponding to amino acids 51-62 of the mature human monocyte chemoattractant protein-1 (MCP-1), which inhibits human mononuclear-cell and THP-1-cell migration induced by a wide range of chemokines. For example, peptide 3 inhibited MCP-1-induced THP-1 migration in a transwell assay with an ED50 of approx. 8 microM. Peptide 3 binds directly to THP-1 cells with an association constant of approx. 10 microM, and is therefore likely to be a direct receptor antagonist for CC and CXC chemokine receptors. By performing a structure-function analysis of this peptide, we have identified a sequence variant that shows an approx. 3-4-fold greater potency as an inhibitor of chemokine-induced migration [Leu4Ile11 peptide 3 (1-12)]. Furthermore, unlike peptide 3, which binds to the Duffy antigen receptor for chemokines on human erythrocytes with a similar affinity to the specific chemokine receptors on THP-1 cells, the Leu4Ile11 peptide 3 (1-12) sequence variant shows at least 20-fold greater selectivity for the specific receptors. Derivatives of Leu4Ile11 peptide 3 (1-12) are therefore the best candidates among the molecules we have investigated for use as a chemokine inhibitor in vivo.
我们已鉴定出一种氨基酸序列,称为肽3,它对应于成熟人单核细胞趋化蛋白-1(MCP-1)的51-62位氨基酸,可抑制多种趋化因子诱导的人单核细胞和THP-1细胞迁移。例如,在Transwell实验中,肽3抑制MCP-1诱导的THP-1迁移,半数有效剂量(ED50)约为8微摩尔。肽3以约10微摩尔的缔合常数直接与THP-1细胞结合,因此可能是CC和CXC趋化因子受体的直接受体拮抗剂。通过对该肽进行结构-功能分析,我们鉴定出一种序列变体,其作为趋化因子诱导迁移抑制剂的效力约高3-4倍[Leu4Ile11肽3(1-12)]。此外,与肽3不同,肽3以与THP-1细胞上特定趋化因子受体相似的亲和力与人红细胞上的趋化因子达菲抗原受体结合,而Leu4Ile11肽3(1-12)序列变体对特定受体的选择性至少高20倍。因此,在我们研究的分子中,Leu4Ile11肽3(1-12)的衍生物是用作体内趋化因子抑制剂的最佳候选物。